Innovent Biologics meets primary endpoint for Phase 3 clinical trial, plans to submit NDA
You and Eye: Welcome to the podcast!
Brassica Pharma voluntarily recalls eye ointments for sterility concerns
Thyroid eye disease: The masquerading eye disorder— a guide to accurate diagnosis and collaborative care
As at-home dry eye treatments boom, the importance of compliance rises
New study identifies genes and cell types that potentially contribute to primary open-angle glaucoma formation
2 Commerce Drive Cranbury, NJ 08512